441 related articles for article (PubMed ID: 8630877)
1. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
3. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
[TBL] [Abstract][Full Text] [Related]
4. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
[TBL] [Abstract][Full Text] [Related]
5. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
[TBL] [Abstract][Full Text] [Related]
6. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.
Kessis TD; Slebos RJ; Han SM; Shah K; Bosch XF; Muñoz N; Hedrick L; Cho KR
Am J Pathol; 1993 Nov; 143(5):1398-405. PubMed ID: 8238255
[TBL] [Abstract][Full Text] [Related]
8. p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
Limpaiboon T; Pooart J; Bhattarakosol P; Niruthisard S; Chantratita W; Lulitanond V
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):66-71. PubMed ID: 11023067
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
Günther T; Schneider-Stock R; Rys J; Niezabitowski A; Roessner A
J Cancer Res Clin Oncol; 1997; 123(7):388-94. PubMed ID: 9260591
[TBL] [Abstract][Full Text] [Related]
11. p53 mutations in HPV-negative cervical carcinoma.
Park DJ; Wilczynski SP; Paquette RL; Miller CW; Koeffler HP
Oncogene; 1994 Jan; 9(1):205-10. PubMed ID: 8302581
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
Helland A; Karlsen F; Due EU; Holm R; Kristensen G; Børresen-Dale Al
Br J Cancer; 1998 Jul; 78(1):69-72. PubMed ID: 9662253
[TBL] [Abstract][Full Text] [Related]
14. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations.
Günther T; Schneider-Stock R; Häckel C; Kasper HU; Pross M; Hackelsberger A; Lippert H; Roessner A
Mod Pathol; 2000 Jun; 13(6):621-6. PubMed ID: 10874665
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
Yin CM; Yao YF; Yan ZL; Yang HY
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
[No Abstract] [Full Text] [Related]
16. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
Iwasaka T; Oh-uchida M; Matsuo N; Yokoyama M; Fukuda K; Hara K; Fukuyama K; Hori K; Sugimori H
Gynecol Oncol; 1993 Jan; 48(1):104-9. PubMed ID: 8380785
[TBL] [Abstract][Full Text] [Related]
17. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
18. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.
Hoppe-Seyler F; Butz K
J Virol; 1993 Jun; 67(6):3111-7. PubMed ID: 8388491
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC
Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
[TBL] [Abstract][Full Text] [Related]
20. Higher incidence of p53 mutation in cervical carcinomas with intermediate-risk HPV infection.
Kim HJ; Song ES; Hwang TS
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):213-8. PubMed ID: 11574134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
